Chateal Eq
Product Images NDC 67296-1652

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Chateal Eq (NDC 67296-1652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Levo Ethi Fig1)

A horizontal bar chart showing the number of women with a blood clot per 10,000 woman years (WY) across four groups: Non-Pregnant Non-COC users, COC users, Pregnancy, and Postpartum (12 weeks only). The chart indicates increasing risk from Non-Pregnant Non-COC users with 1 to 5 cases up to Postpartum with 40 to 65 cases, with Pregnancy and COC users showing intermediate ranges.*

FDA Label Image

Figure (Levo Ethi Fig2)

Forest plot chart comparing effect estimates between ever use and current use of combined oral contraceptives (COC) versus never use. It displays multiple studies with their effect estimates, odds ratios (OR), risk ratios (RR), and hazard ratios (HR), along with confidence intervals, plotted against an effect estimate scale from -1.50 to 2.00.*

FDA Label Image

Figure 3 (Levo Ethi Fig3)

An illustration showing a vertical scale indicating pregnancy frequency ranging from fewer pregnancies (fewer than 1 pregnancy per 100 women per year) at the top to more pregnancies (85 or more pregnancies per 100 women per year) at the bottom. The scale categorizes contraceptive methods including implants, injections, intrauterine devices, sterilization (top, fewer pregnancies); birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm (middle); and no sex during fertile days, spermicide, withdrawal, no birth control (bottom, more pregnancies).*

FDA Label Image

Figure 4 (Levo Ethi Fig4)

Figure A is an illustrated dosing calendar for Chateal EQ (Levonorgestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg). It shows four rows of seven circles each labeled by day of the week (SUN to SAT). The first three rows correspond to orange tablets for Weeks 1 to 3 and the fourth row corresponds to green tablets for Week 4. The diagram includes storage temperature instructions and an example NDC number for reference.*

FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg (28 Tablets Pouch))

Box label for Chateal EQ (Levonorgestrel and Ethinyl Estradiol Tablets USP) 0.15 mg/0.03 mg from afaxys pharma. The label indicates a blister card containing 28 tablets, including 21 orange active tablets and 7 green inert tablets. Manufacturer and product codes, storage instructions, and sealing areas are shown on the label.*

FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg (84 Tablets Carton))

Chateal EQ tablets packaging label showing the proprietary name, active ingredients Levonorgestrel and Ethinyl Estradiol, and strength of 0.15 mg/0.03 mg. The label indicates a package containing 3 pouches of 28 tablets each, with directions for use and manufacturer information for Afaxys Pharma, LLC and Aurobindo Pharma Limited. The design features a wavy pattern in orange and brown on a white background.*

FDA Label Image

Chemical Structure1 (Levo Ethi Str1)

Chemical structure of Levonorgestrel, showing its molecular framework with molecular formula C21H28O2 and a molecular weight of 312.4. The diagram includes various carbon rings, hydroxyl group, and a triple bond characteristic in its structure.*

FDA Label Image

Chemical Structure2 (Levo Ethi Str2)

Chemical structure diagram of Ethinyl Estradiol, showing its molecular formula C20H24O2 and molecular weight 296.4, with detailed depiction of its steroid nucleus and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.